Norroy Bioscience Initiates Pivotal Phase III Clinical Trial of 177Lu-NYM032, a PSMA-Targeted Radioligand Therapy for mCRPC WUXI, China, Sept. 2, 2026 /PRNewswire/ — NORROY BIOSCIENCE (NORROY), a clinical-stage… CISION PRNewswireSeptember 2, 2026
Yatsen Announces Second Quarter 2026 Financial Results Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on… CISION PRNewswireSeptember 2, 2026
Press ReleaseCNN Academy expands to Japan to empower future multimedia storytellers HONG KONG, Sept. 2, 2026 /PRNewswire/ — CNN has successfully concluded the inaugural… CISION PRNewswireSeptember 2, 2026
LifestylePress ReleaseTechDreame Technology Unveils New X60 Ultra Extreme and Next-Generation Smart Lifestyle Solutions at COMEX 2026 SINGAPORE, Sept. 2, 2026 /PRNewswire/ — Dreame Technology, a global ultra-premium AI‑powered… CISION PRNewswireSeptember 2, 2026
Press ReleaseBTL Establishes New Laser Division and Introduces EXOLASE ONE® – The World's First Fused Erbium Laser Proprietary technology fuses multiple wavelengths into a single beam to set a… CISION PRNewswireSeptember 2, 2026
Thunes Champions Ethical Global Payments with its 2026 United Nations Global Compact Commitment Thunes’ latest Communication on Progress outlines how the company reinforces responsible business… CISION PRNewswireSeptember 2, 2026
Press ReleaseRingConn Showcases Gen 3 Smart Ring at IFA 2026 Visit RingConn at Hall 14, Booth 121 during IFA 2026 to discover… CISION PRNewswireSeptember 2, 2026
Press ReleaseFibocom Launches RU311 5G RedCap Module Series for Streamlined 5G Upgrades in Mid-Tier IoT SHENZHEN, China, Sept. 2, 2026 /PRNewswire/ — For many IoT devices, upgrading to… CISION PRNewswireSeptember 2, 2026
